Is this you?
Request access for Axon Clinical Research with your @axonclinicalresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Axon Clinical Research
Unclaimed profileSite Network · Los Angeles, California · ~5 sites
Intera lens
ICP 7Lift (cardio sample) 0.16Recruit soph 0.29
Quality Scorecard (1–100)
Overall61Recruit64Ops61Sponsor62Ther55
Performance (observed)
Historical trials
134
Completed
66
Terminated/Withdrawn
18
Completion rate
79%
Active now
47
Phase 2
39
Phase 3
93
Realized enrollment
271,055
First study year
2015
Years active
11
Match confidence
low
Enrollment velocity (inf)
24,641
Therapeutic
Areas
Dermatology, Multi-specialty, Vaccines, CNS, Diverse indications
Specialties
Diverse - consumer health, beauty, haircare, OTC, emerging products, phase I-IV
Breadth (conditions)
112
Languages
English + Spanish (detected)
States
California, Texas, Maryland, Georgia, Washington (+ Africa)
Recruitment (web observed)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Active website with careers/capabilities pages
Capability notes
Diversity-focused recruitment; 250+ years collective experience; targets underrepresented populations (Black/Latino); AI-driven PI development
Relationships
Sponsors
AbbVie; Janssen Research & Development, LLC; Eli Lilly and Company; Takeda; Hoffmann-La Roche; Bayer
CROs
IQVIA Pty Ltd; Medpace, Inc.; Parexel; Premier Research; Syneos Health
Partnerships
Africa network partnerships
Owner / parent
Unknown
Acquisitions
N
Expansion
Y - U.S. and Africa expansion
Recent hiring
Careers page active (join-us section)
Capacity & people
Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown
Tech & DCT
Uses AI
Yes
Builds tech
Builds (AI-driven recruitment)
DCT / decentralized
Y - focus on decentralized trials, remote monitoring
Tech stack
AI-driven recruitment platform (implied); GCP, HIPAA, SOPs
Recruiting visible
Y
Notes
Good Intera fit: Diversity-focused recruitment innovation; mentions DCT/decentralized trials; AI-driven approach to PI development; multi-state presence; actively advertises patient recruitment. Limited site count (5 wholly-owned) but strong innovation signal. Mission-driven appeal for underrepresented populations aligns with Intera values.
Recommendation features (sample indication)
Ind fit 0.22Liftability 0.16Overall61
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.